Cell-Based Therapies in Lower Urinary Tract Disorders. Issue 9 (September 2015)

• Record Type: Journal Article
• Authors: Gopinath, Chaitanya; Ponsaerts, Peter; Wyndaele, Jean Jacques
• Is Part Of: Cell transplantation. Volume 24:Issue 9(2015)
• Page Start: 1679
• Page End: 1686
• Publication Date: 2015-09
• Subjects: Cell transplantation -- Bladder -- Literature review -- Tissue engineering -- Urology; Cell transplantation -- Periodicals; Cell Transplantation; Cell transplantation; Electronic journals; Periodicals; Periodicals; 571.638
• DOI: 10.3727/096368914X685050
• Languages: English
• ISSNs: 0963-6897

Abstract

Cell-based therapy for the bladder has its beginnings in the 1990s with the successful isolation and culture of bladder smooth muscle cells. Since then, several attempts have been made to artificially implant native cell types and stem cell-derived cells into damaged bladders in the form of single-cell injectables or as grafts seeded onto artificial extracellular matrix. We critically examined in the literature the types of cells and their probable role as an alternative to non-drug-based, non-bowel-based graft replacement therapy in disorders of the urinary bladder. The limitations and plausible improvements to these novel therapies have also been discussed, keeping in mind an ideal therapy that could suit most bladder abnormalities arising out of varied number of disorders. In conclusion, muscle-derived cell types have consistently proven to be a promising therapy to emerge in the coming decade. However, tissue-engineered constructs have yet to prove their success in preclinical and long-term clinical setting.